Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stewart Cole

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Future Microbiology|June 29, 2011
Antimicrobial drug discoveryAlan Fairlamb, Stewart Cole
The Lancet. Infectious Diseases|March 28, 2013
Tuberculosis biomarkers discovery: developments, needs, and challengesRobert S Wallis, Peter Kim, Stewart Cole, et al.
Journal of Clinical Microbiology|September 4, 2009
Lack of insertional-deletional polymorphism in a collection of Mycobacterium ulcerans isolates from Ghanaian Buruli ulcer patientsMichael Käser, Oliver Gutmann, Julia Hauser, et al.
Nature Medicine|March 8, 2007
Reply to 'Alice Dautry' profileAntónio Bandeira, Françoise Barré-Sinoussi, Pierre-André Cazenave, et al.
Molecular Pharmaceutics|December 29, 2021
Machine Learning Models for <i>Mycobacterium tuberculosis</i><i>In Vitro</i> Activity: Prediction and Target VisualizationThomas R Lane, Fabio Urbina, Laura Rank, et al.
Lancet (London, England)|May 22, 2012
Scaling up interventions to achieve global tuberculosis control: progress and new developmentsMario Raviglione, Ben Marais, Katherine Floyd, et al.
Tuberculosis (Edinburgh, Scotland)|July 24, 2012
Detection and treatment of subclinical tuberculosisBrian D Robertson, Danny Altmann, Clif Barry, et al.
The Lancet. Infectious Diseases|March 28, 2013
Drug-resistant tuberculosis: time for visionary political leadershipIbrahim Abubakar, Matteo Zignol, Dennis Falzon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Future Microbiology|June 29, 2011
Antimicrobial drug discoveryAlan Fairlamb, Stewart Cole
The Lancet. Infectious Diseases|March 28, 2013
Tuberculosis biomarkers discovery: developments, needs, and challengesRobert S Wallis, Peter Kim, Stewart Cole, et al.
Journal of Clinical Microbiology|September 4, 2009
Lack of insertional-deletional polymorphism in a collection of Mycobacterium ulcerans isolates from Ghanaian Buruli ulcer patientsMichael Käser, Oliver Gutmann, Julia Hauser, et al.
Nature Medicine|March 8, 2007
Reply to 'Alice Dautry' profileAntónio Bandeira, Françoise Barré-Sinoussi, Pierre-André Cazenave, et al.
Molecular Pharmaceutics|December 29, 2021
Machine Learning Models for <i>Mycobacterium tuberculosis</i><i>In Vitro</i> Activity: Prediction and Target VisualizationThomas R Lane, Fabio Urbina, Laura Rank, et al.
Lancet (London, England)|May 22, 2012
Scaling up interventions to achieve global tuberculosis control: progress and new developmentsMario Raviglione, Ben Marais, Katherine Floyd, et al.
Tuberculosis (Edinburgh, Scotland)|July 24, 2012
Detection and treatment of subclinical tuberculosisBrian D Robertson, Danny Altmann, Clif Barry, et al.
The Lancet. Infectious Diseases|March 28, 2013
Drug-resistant tuberculosis: time for visionary political leadershipIbrahim Abubakar, Matteo Zignol, Dennis Falzon, et al.
Pageof 1